Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Amortization of Goodwill (2020)

Historic Amortization of Goodwill for Anika Therapeutics (ANIK) over the last 1 years, with Q4 2020 value amounting to $24.4 million.

  • Anika Therapeutics' Amortization of Goodwill changed N/A to $24.4 million in Q4 2020 from the same period last year, while for Sep 2021 it was $24.4 million, marking a year-over-year increase of 3447.97%. This contributed to the annual value of $42.5 million for FY2020, which is N/A changed from last year.
  • Per Anika Therapeutics' latest filing, its Amortization of Goodwill stood at $24.4 million for Q4 2020.
  • Anika Therapeutics' Amortization of Goodwill's 5-year high stood at $24.4 million during Q4 2020, with a 5-year trough of $18.1 million in Q1 2020.